Status:
UNKNOWN
Impact of Isotretinoin in Different Doses on Quality of Life
Lead Sponsor:
Assiut University
Conditions:
Acne Vulgaris
Eligibility:
All Genders
12-45 years
Phase:
PHASE4
Brief Summary
The Cardiff Acne Disability Index is a short five-item questionnaire derived from the longer Acne Disability Index.It is designed for use in teenagers and young adults with acne. It is self explanator...
Detailed Description
Lower doses of isotretinoin can be effective in terms of cost and decreasing systemic side effects. Therefore, other regimens may be used instead of daily conventional dose as alternate, pulse and low...
Eligibility Criteria
Inclusion
- Patients with clinically diagnosed acne vulgaris older than 18 years of age
- \-
Exclusion
- Patients having personal or family history of hyperlipidemia. Pregnancy and lactation. Newly married female desiring to get pregnant or using temporary method of contraception.
- Patients with a history suggestive of any psychic disturbance -
Key Trial Info
Start Date :
December 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05316675
Start Date
December 1 2022
End Date
December 1 2024
Last Update
April 7 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.